Organising pneumonia (OP) is a distinct pathological pattern characterised by the presence of granulation tissue buds composed of fibroblasts and myofibroblasts embedded in a loose connective tissue matrix within the distal pulmonary airspaces. When OP occurs without an identifiable cause or etiologic context, it is termed cryptogenic organising pneumonia (COP). The diagnosis of OP can be challenging due to its diverse clinical presentations, including the idiopathic form and various secondary forms associated with underlying diseases. We report a case of a middle-aged male presenting with intermittent cough and haemoptysis. Initial sputum analysis was unremarkable, and the patient showed no improvement with antibiotic therapy. Chest radiography showed left lower zone consolidation. Computed tomography (CT) thorax revealed a mass in the left lower lobe, while positron emission tomography-computed tomography (PET/CT) demonstrated a hypermetabolic lesion at the same site. Bronchoscopic bronchoalveolar lavage was negative for tuberculosis, respiratory pathogens, and malignancy. Autoimmune screening yielded negative results. A transthoracic tru-cut lung biopsy confirmed the diagnosis of OP. The patient was treated with prednisolone, leading to significant clinical improvement and complete resolution of the lesion on follow-up CT imaging.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11880684 | PMC |
http://dx.doi.org/10.1002/rcr2.70138 | DOI Listing |
Arch Rheumatol
December 2024
Department of Internal Medicine, Division of Rheumatology, Akdeniz University Faculty of Medicine, Antalya, Türkiye.
Objectives: The study aimed to describe the prevalence and patterns of pulmonary lesions in the patients with psoriatic arthritis (PsA).
Patients And Methods: Pulmonary symptoms and thorax imaging findings of 247 patients (155 females, 92 males, mean age: 52.0±12.
Rev Med Chil
October 2024
Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Unlabelled: Organized pneumonia (OP) is an uncommon disease included in the group of idiopathic interstitial pneumonias. It can be cryptogenic (COP) or secondary to various etiologies. Its diagnosis is complex and not standardized.
View Article and Find Full Text PDFFront Immunol
March 2025
Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
The immunocompromised population is susceptible to pneumonia. The diagnosis and treatment of pneumonia in immunocompromised individuals are challenging clinical endeavors. Previous studies have identified pneumonia as a potential cause of organizing pneumonia (OP), however, the association between pneumonia and OP has not received enough clinical attention.
View Article and Find Full Text PDFRespirol Case Rep
March 2025
Respiratory Unit, Department of Medicine, Hospital Canselor Tuanku Muhriz, Faculty of Medicine Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia.
Organising pneumonia (OP) is a distinct pathological pattern characterised by the presence of granulation tissue buds composed of fibroblasts and myofibroblasts embedded in a loose connective tissue matrix within the distal pulmonary airspaces. When OP occurs without an identifiable cause or etiologic context, it is termed cryptogenic organising pneumonia (COP). The diagnosis of OP can be challenging due to its diverse clinical presentations, including the idiopathic form and various secondary forms associated with underlying diseases.
View Article and Find Full Text PDFRespir Investig
March 2025
National Cancer Center Hospital, Department of Thoracic Oncology, 5 Chome-1-1 Tsukiji, Chuo City, Tokyo, 104-0045, Japan.
Background: Part D of the open-label, phase 1 KEYNOTE-011 study (ClinicalTrials.gov, NCT01840579) evaluated the safety and tolerability, pharmacokinetics, and antitumor activity of pembrolizumab plus ipilimumab as first-line treatment in Japanese participants with advanced NSCLC.
Methods: Eligible participants were aged ≥20 years with previously untreated stage IIIB/IV NSCLC (any tumor PD-L1 status permitted).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!